Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
GERON CORP | Director | Common Stock | 170K | $776K | $4.56 | Sep 30, 2024 | Direct |
Cyclacel Pharmaceuticals, Inc. | Director | Common Stock | 39.4K | $131K | $3.32 | Jun 30, 2023 | Direct |
RenovoRx, Inc. | Director | Common Stock | 41K | $42.8K | $1.05 | Jan 26, 2024 | Direct |
Athenex, Inc. | Director | Common Stock | 4.59K | $6.25K | $1.36 | Apr 21, 2023 | Direct |
GERON CORP | Director | Stock Option (right to buy) | 180K | May 9, 2024 | Direct | ||
Cyclacel Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 42.4K | Jun 30, 2023 | Direct | ||
RenovoRx, Inc. | Director | Warrants | 41K | Jan 26, 2024 | Direct | ||
RenovoRx, Inc. | Director | Stock Options (right to buy) | 25.1K | Oct 1, 2023 | Direct | ||
RenovoRx, Inc. | Director | Stock Options (right to buy) | 25.1K | Oct 1, 2024 | Direct | ||
Ayala Pharmaceuticals, Inc. | Director | Stock Option | 1.17K | Jan 19, 2023 | Direct | ||
Athenex, Inc. | Director | Stock Option (Right to Buy) | 875 | Apr 21, 2023 | Direct | ||
Old Ayala, Inc | Director | Stock Option (right to buy) | 0 | Jan 19, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RNXT | RenovoRx, Inc. | Oct 1, 2024 | 1 | $0 | 4 | Oct 2, 2024 | Director |
GERN | GERON CORP | Sep 30, 2024 | 1 | $0 | 4 | Oct 1, 2024 | Director |
GERN | GERON CORP | May 9, 2024 | 1 | $0 | 4 | May 10, 2024 | Director |
GERN | GERON CORP | Mar 29, 2024 | 2 | $0 | 4 | Jun 28, 2024 | Director |
RNXT | RenovoRx, Inc. | Jan 26, 2024 | 2 | $0 | 4 | Jan 30, 2024 | Director |
GERN | GERON CORP | Dec 29, 2023 | 1 | $0 | 4 | Jan 3, 2024 | Director |
RNXT | RenovoRx, Inc. | Oct 1, 2023 | 1 | $0 | 4 | Oct 2, 2023 | Director |
GERN | GERON CORP | Sep 29, 2023 | 1 | $0 | 4 | Oct 2, 2023 | Director |
CYCC | Cyclacel Pharmaceuticals, Inc. | Jun 30, 2023 | 2 | $0 | 4 | Jul 3, 2023 | Director |
GERN | GERON CORP | Jun 30, 2023 | 1 | $0 | 4 | Jun 30, 2023 | Director |
GERN | GERON CORP | May 31, 2023 | 1 | $0 | 4 | Jun 2, 2023 | Director |
RNXT | RenovoRx, Inc. | Apr 25, 2023 | 1 | $0 | 4 | Apr 27, 2023 | Director |
RNXT | RenovoRx, Inc. | Apr 25, 2023 | 0 | $0 | 3 | Apr 27, 2023 | Director |
ATNXQ | Athenex, Inc. | Apr 21, 2023 | 1 | $3K | 4 | Apr 24, 2023 | Director |
GERN | GERON CORP | Mar 31, 2023 | 1 | $0 | 4 | Apr 3, 2023 | Director |
AYLA | Old Ayala, Inc | Jan 19, 2023 | 4 | $0 | 4 | Jan 23, 2023 | Director |
ADXS | Ayala Pharmaceuticals, Inc. | Jan 19, 2023 | 4 | $0 | 4 | Jan 23, 2023 | Director |
ADXS | Ayala Pharmaceuticals, Inc. | Jan 19, 2023 | 0 | $0 | 3 | Jan 23, 2023 | Director |
ATNXQ | Athenex, Inc. | Jan 13, 2023 | 1 | $3K | 4 | Jan 17, 2023 | Director |
GERN | GERON CORP | Dec 30, 2022 | 1 | $0 | 4 | Jan 3, 2023 | Director |
ATNXQ | Athenex, Inc. | Oct 7, 2022 | 1 | $3K | 4 | Oct 12, 2022 | Director |
GERN | GERON CORP | Sep 30, 2022 | 1 | $0 | 4 | Oct 3, 2022 | Director |
ATNXQ | Athenex, Inc. | Aug 3, 2022 | 2 | $0 | 4 | Aug 30, 2022 | Director |
ATNXQ | Athenex, Inc. | Jul 20, 2022 | 1 | $3K | 4 | Jul 21, 2022 | Director |
GERN | GERON CORP | Jun 30, 2022 | 1 | $0 | 4 | Jul 1, 2022 | Director |
ATNXQ | Athenex, Inc. | Jun 28, 2022 | 1 | $0 | 4 | Jun 29, 2022 | Director |
CYCC | Cyclacel Pharmaceuticals, Inc. | Jun 14, 2022 | 2 | $0 | 4 | Jun 16, 2022 | Director |
AYLA | Ayala Pharmaceuticals, Inc. | Jun 13, 2022 | 1 | $0 | 4 | Jun 15, 2022 | Director |
GERN | GERON CORP | May 10, 2022 | 1 | $0 | 4 | May 11, 2022 | Director |
ATNXQ | Athenex, Inc. | Apr 8, 2022 | 1 | $3K | 4 | Apr 11, 2022 | Director |
GERN | GERON CORP | Mar 31, 2022 | 1 | $0 | 4 | Apr 1, 2022 | Director |
GERN | GERON CORP | Dec 31, 2021 | 1 | $0 | 4 | Jan 3, 2022 | Director |
GERN | GERON CORP | Sep 30, 2021 | 1 | $0 | 4 | Oct 1, 2021 | Director |
ATNXQ | Athenex, Inc. | Aug 3, 2021 | 2 | $0 | 4 | Aug 5, 2021 | Director |
GERN | GERON CORP | Jun 30, 2021 | 1 | $0 | 4 | Jul 1, 2021 | Director |
CYCC | Cyclacel Pharmaceuticals, Inc. | Jun 15, 2021 | 2 | $0 | 4 | Jun 17, 2021 | Director |
AYLA | Ayala Pharmaceuticals, Inc. | Jun 10, 2021 | 1 | $0 | 4 | Jun 14, 2021 | Director |
GERN | GERON CORP | May 11, 2021 | 1 | $0 | 4 | May 13, 2021 | Director |